ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below 200-Day Moving Average - Here's Why
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Passes Below 200 Day Moving Average - Here's What Happened...
MarketBeat·11h ago
More News
NVO Reports Strong Phase III Diabetes Data for Children & Adolescents
Novo Nordisk reports phase III teen study success for oral semaglutide, showing strong HbA1c reduction and paving the way for the first oral GLP-1 for youth.
Zacks·1d ago
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·1d ago
KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data
Kura Oncology shares jump 8% as FIT-001 data show strong tumor response and disease control with darlifarnib combination in pretreated renal cancer patients.
Zacks·5d ago
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics
ANIP eyes 2026 growth via Cortrophin's gout push and steady generics launches, as Rare Disease expansion reshapes priorities and investor focus.
Zacks·5d ago
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target?
ANI Pharmaceuticals trades at 10x forward earnings with a $93 target, but execution in Cortrophin and ophthalmology recovery may decide if the discount closes.
Zacks·5d ago
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook
ANI Pharmaceuticals rides Cortrophin Gel's surge to anchor 2026 growth, with rising guidance and new initiatives positioning the specialty portfolio for continued momentum.
Zacks·5d ago
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·5d ago
Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
ANI (ANIP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·8d ago
How Much Upside is Left in ANI (ANIP)? Wall Street Analysts Think 41.71%
The consensus price target hints at a 41.7% upside potential for ANI (ANIP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.